Bioregenx, Inc. financial data

Symbol
BRGX on OTC
Location
7407 Ziegler Road, Chattanooga, TN
State of incorporation
Nevada
Fiscal year end
December 31
Former names
FINDIT, INC. (to 1/18/2024), ARTEMIS ENERGY HOLDINGS, INC. (to 12/11/2013)
Latest financial report
10-Q/A - Q1 2024 - May 29, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 0.37 %
Debt-to-equity 44.4 %
Return On Equity -45.3 % -199%
Return On Assets -31.4 %
Operating Margin 129 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 957M shares +246%
Common Stock, Shares, Outstanding 957M shares +246%
Entity Public Float 4.24M USD +351%
Common Stock, Value, Issued 957K USD +246%
Weighted Average Number of Shares Outstanding, Basic 768M shares +24%
Weighted Average Number of Shares Outstanding, Diluted 819M shares +32.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenues -435K USD -139%
Cost of Revenue 159K USD -48.9%
Operating Income (Loss) -562K USD -150%
Nonoperating Income (Expense) -484K USD -958%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -1.75M USD -546%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -1.75M USD -546%
Earnings Per Share, Basic 0 USD/shares
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 114K USD
Accounts Receivable, after Allowance for Credit Loss, Current 103K USD
Inventory, Net 409K USD
Other Assets, Current 173K USD
Assets, Current 758 USD
Property, Plant and Equipment, Net 581K USD
Intangible Assets, Net (Excluding Goodwill) 17.1M USD
Other Assets, Noncurrent 101 USD
Assets 20.5M USD +26206%
Accounts Payable, Current 613K USD
Accrued Liabilities, Current 566K USD
Liabilities, Current 3.35M USD +8478%
Liabilities 3.5M USD +1392%
Accumulated Other Comprehensive Income (Loss), Net of Tax 99 USD
Retained Earnings (Accumulated Deficit) -10.2M USD -195%
Stockholders' Equity Attributable to Parent 17M USD
Liabilities and Equity 20.5M USD +26206%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 37K USD
Net Cash Provided by (Used in) Financing Activities 19M USD +11368%
Net Cash Provided by (Used in) Investing Activities -19M USD
Common Stock, Shares Authorized 1.5B shares +200%
Common Stock, Shares, Issued 957M shares +246%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -11.2K USD +93.3%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 114K USD -74.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 737K USD +20.2%
Payments to Acquire Property, Plant, and Equipment 588K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -1.07M USD -229%
Deferred Tax Assets, Operating Loss Carryforwards 737K USD +20.2%
Unrecognized Tax Benefits 0 USD
Additional Paid in Capital 25.9M USD +764%
Depreciation, Depletion and Amortization 20.7K USD
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Interest Expense 8.28K USD